Investors

Investor Relations

DISCOVERING AND DEVELOPING NOVEL THERAPIES THAT CAN OVERCOME RESISTANCE IN CANCER

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Press
Releases
November 25, 2024

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

November 12, 2024

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

Upcoming
Events
More events are coming soon.
INVESTOR
CONTACT

ORIC Pharmaceuticals’ investor relations department can be reached via email at investors@oricpharma.com.

Contact